Trump heads to Beijing for high-stakes Xi summit this week

Despite 10 weeks of Middle East chaos and a fractious Iran peace effort, Trump is pressing ahead with a state visit to China this week. The summit comes at a delicate moment: the US has just rejected Iran's peace overture, oil prices are spiking, and Wall Street is hunting for any narrative that might stabilize risk sentiment. Beijing has officially confirmed the visit, billing it as an opportunity to 'stabilize and refine China-US relations.' The timing sends a signal that both capitals see value in preventing further geopolitical unraveling.

The corporate entourage provides a clue to negotiation priorities. Attendees include Boeing, Qualcomm, Broadcom, Visa, Citigroup, Exxon, and Apple, according to stocktwits commentary. This roster suggests the trip will cover aerospace deals, semiconductor supply-chain agreements, energy cooperation, and financial services. China's Zhaojin Mining has been scouting gold acquisitions in Africa and Central Asia, targeting assets divested by Western firms; a Trump-Xi meeting might clear regulatory pathways for such cross-border M&A.

Market implications are bullish for US equities contingent on deal flow. If Trump and Xi agree on a trade framework pause or sectoral exemptions (semiconductors, defense, energy), risk sentiment could re-inflate. The Mag 7 and semiconductor names would benefit most from a 'peace trade.' However, any announcements of new US-China restrictions on advanced chips or defense tech could reverse the move sharply. SK Hynix and Samsung labor talks (strike threatened May 21) also add a wildcard; resolution before Trump's China visit could defuse memory-chip supply concerns.

The broader debate: is this summit a true thaw or a tactical pause? Skeptics note that Trump has maintained 10% global tariffs despite a court ruling them unlawful, suggesting ideological rigidity on trade policy. But with oil prices threatening to derail the macro backdrop and equity valuations dependent on AI capex, both sides have incentive to avoid escalation. China has timed a joint US drug bust announcement for just before the summit, signaling cooperation on bilateral issues.